ImmunoGen Inc. (IMGN)
NASDAQ: IMGN
· Real-Time Price · USD
31.23
0.00 (0.00%)
At close: Feb 09, 2024, 9:58 PM
ImmunoGen Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | 35.27 | -292.56 | -6.13 | -5.32 | -3.84 | -4.52 | -11.85 | -10.52 | -7.78 | -10.71 | -11.82 |
PEG Ratio | -0.05 | 3.25 | 0.20 | 0.21 | -0.16 | -0.03 | 0.29 | 1.89 | -0.39 | 0.91 | 0.06 |
PS Ratio | 38.24 | 59.78 | 19.93 | 30.51 | 77.98 | 80.50 | 31.66 | 55.89 | 126.11 | 77.72 | 102.54 |
PB Ratio | 7.72 | 10.13 | 8.15 | 8.06 | 6.74 | 4.56 | 3.93 | 4.81 | 15.07 | 19.24 | 17.11 |
P/FCF Ratio | 3.06K | -74.4 | -13.45 | -20.78 | -18.5 | -17.76 | -28.9 | -33.83 | -33.03 | -29.99 | -35.39 |
P/OCF Ratio | 1.57K | -74.49 | -13.48 | -20.87 | -18.67 | -17.82 | -29.12 | -34.11 | -33.14 | -30.02 | -36.09 |
OCF/S Ratio | 0.02 | -0.8 | -1.48 | -1.46 | -4.18 | -4.52 | -1.09 | -1.64 | -3.8 | -2.59 | -2.84 |
Debt / Equity Ratio | 0.13 | 0.15 | 0.12 | 0.10 | 0.09 | 0.07 | 0.06 | 0.06 | 0.25 | 0.31 | 0.25 |
Quick Ratio | 5.43 | 6.07 | 1.97 | 2.12 | 3.19 | 4.52 | 5.43 | 4.95 | 2.42 | 2.28 | 2.38 |
Current Ratio | 5.47 | 6.10 | 1.98 | 2.26 | 3.19 | 4.29 | 5.43 | 4.74 | 2.20 | 1.99 | 2.11 |
Asset Turnover | 0.14 | 0.12 | 0.17 | 0.12 | 0.04 | 0.03 | 0.08 | 0.05 | 0.03 | 0.06 | 0.05 |
Interest Coverage | 24.63 | -3.88 | -49.7 | -61.34 | -89.31 | -56.64 | -18.3 | -16.06 | -12.44 | -7.64 | -6.19 |
Return on Equity | 0.05 | -0.01 | -0.33 | -0.38 | -0.44 | -0.25 | -0.08 | -0.11 | -0.48 | -0.45 | -0.36 |
Return on Assets | 0.04 | -0.01 | -0.14 | -0.17 | -0.22 | -0.15 | -0.05 | -0.07 | -0.13 | -0.1 | -0.1 |
Return on Invested Capital | 0.04 | -0.01 | -0.22 | -0.26 | -0.3 | -0.18 | -0.06 | -0.08 | -0.18 | -0.15 | -0.13 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.98 | 0.99 | 0.99 | 1.00 | 0.97 | 1.00 | 1.00 | -0.23 | 1.00 | 1.00 | -1.19 |
Net Profit Margin | 0.27 | -0.05 | -0.81 | -1.43 | -5.08 | -4.45 | -0.67 | -1.33 | -4.05 | -1.81 | -2.17 |
Pretax Profit Margin | 0.26 | -0.04 | -0.82 | -1.4 | -5.06 | -4.38 | -0.63 | -1.33 | -4.05 | -1.81 | -2.17 |
Operating Profit Margin | 0.23 | -0.05 | -0.85 | -1.45 | -5.04 | -4.31 | -0.6 | -1.23 | -3.72 | -1.61 | -1.84 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | 0.27 | -0.03 | -0.81 | -1.38 | -5.07 | -4.3 | -0.59 | -1.25 | -3.76 | -1.6 | -1.87 |